Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Voyager Therapeut (VYGR)

Voyager Therapeut (VYGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 411,704
  • Shares Outstanding, K 37,191
  • Annual Sales, $ 104,390 K
  • Annual Income, $ -43,600 K
  • 60-Month Beta 1.93
  • Price/Sales 4.08
  • Price/Cash Flow N/A
  • Price/Book 5.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.75
  • Number of Estimates 6
  • High Estimate -0.55
  • Low Estimate -0.92
  • Prior Year 0.29
  • Growth Rate Est. (year over year) -358.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.87 +2.81%
on 07/31/20
13.99 -20.12%
on 07/15/20
-1.72 (-13.37%)
since 07/02/20
3-Month
10.31 +8.39%
on 05/04/20
14.62 -23.56%
on 06/23/20
+0.60 (+5.62%)
since 05/01/20
52-Week
6.26 +78.51%
on 03/16/20
23.50 -52.45%
on 08/09/19
-10.11 (-47.49%)
since 08/02/19

Most Recent Stories

More News
Homology Medicines (FIXX) Looks Good: Stock Adds 8% in Session

Homology Medicines (FIXX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

VYGR : 11.17 (+0.90%)
FIXX : 13.93 (+5.93%)
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, has entered into an employment agreement...

VYGR : 11.17 (+0.90%)
Should You Buy Voyager Therapeutics (VYGR) Ahead of Earnings?

Voyager Therapeutics (VYGR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

VYGR : 11.17 (+0.90%)
Voyager Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates

Announced 14 presentations at upcoming American Society of Gene and Cell Therapy (ASGCT) Virtual Annual Meeting highlighting Huntington's disease, ALS SOD1, vectorized antibodies, novel capsids, and manufacturing...

VYGR : 11.17 (+0.90%)
Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2020 Annual Meeting

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced multiple data presentations...

VYGR : 11.17 (+0.90%)
Innovative Approaches to Healthcare Lead to the Psychedelic Biotech Market's Inception

The fast pace of technological change in the biotechnology industry and the shifting market demands require continuous innovation. This, in turn, puts pressure on companies to invest in Research and Development....

SHRMF : 0.4189 (-0.24%)
SHRM.CN : 0.890 (+3.49%)
SEEL : 1.0800 (-6.90%)
JNJ : 147.23 (+1.01%)
OSUR : 19.06 (+5.01%)
VYGR : 11.17 (+0.90%)
Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced that it has hired Robert Pietrusko, PharmD, as Chief Regulatory and...

VYGR : 11.17 (+0.90%)
Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson's Disease Trial

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today provided an update on the RESTORE-1...

NBIX : 122.33 (+1.64%)
VYGR : 11.17 (+0.90%)
Voyager Therapeutics Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference

Voyager Therapeutics, Inc. (NASDAQ: VYGR) announced today the cancellation of the Company's presentation and webcast at the Barclays Global Healthcare Conference, previously scheduled to take place on...

VYGR : 11.17 (+0.90%)
Voyager Therapeutics: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $12.6 million in its fourth quarter.

VYGR : 11.17 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade VYGR with:

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

2nd Resistance Point 11.68
1st Resistance Point 11.38
Last Price 11.17
1st Support Level 10.82
2nd Support Level 10.56

See More

52-Week High 23.50
Fibonacci 61.8% 16.91
Fibonacci 50% 14.88
Fibonacci 38.2% 12.85
Last Price 11.17
52-Week Low 6.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar